Financial Information for the Company and Its Subsidiaries (Tables)

6 Months Ended

Jun. 30, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]



Condensed Consolidating Balance Sheet - June 30, 2016 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	4,591	$	16,215	$	53,299	$	—		$	74,105
Restricted cash and marketable securities	—		—		12,794		—			12,794
Accounts receivable, net	—		258,863		116,489		—			375,352
Supplies inventory	—		—		21,980		—			21,980
Prepaid and other current assets	45,542		24,074		26,261		(21,312		)	74,565
Total current assets	50,133		299,152		230,823		(21,312		)	558,796
Property and equipment, net	11,877		27,822		165,223		—			204,922
Investments in and receivables from unconsolidated affiliates	5,219,975		1,807,424		—		(6,848,343		)	179,056
Goodwill	—		2,123,067		—		2,051,941			4,175,008
Intangible assets, net	13,037		1,664,313		1,925		—			1,679,275
Other assets	7,186		20,825		20,251		(1,999		)	46,263
Total assets	$	5,302,208	$	5,942,603	$	418,222	$	(4,819,713	)	$	6,843,320
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	20	$	12,052	$	—		$	20,772
Accounts payable	3,073		1,640		29,569		(3,561		)	30,721
Accrued salaries and benefits	29,533		140,149		17,226		—			186,908
Accrued interest	30,386		—		14		—			30,400
Other accrued liabilities	5,171		69,166		35,985		(17,751		)	92,571
Total current liabilities	76,863		210,975		94,846		(21,312		)	361,372
Long-term debt	2,550,996		36		56,065		(26,054		)	2,581,043
Deferred income taxes	288,503		456,942		—		(1,998		)	743,447
Other long-term liabilities	8,568		76,144		34,766		—			119,478
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		60,886		116,959			177,845
Equity:
Total AmSurg Corp. equity	2,377,278		3,967,431		125,450		(4,092,881		)	2,377,278
Noncontrolling interests – non-redeemable	—		2,918		46,209		433,730			482,857
Total equity	2,377,278		3,970,349		171,659		(3,659,151		)	2,860,135
Total liabilities and equity	$	5,302,208	$	5,942,603	$	418,222	$	(4,819,713	)	$	6,843,320



Condensed Consolidating Balance Sheet - December 31, 2015 (In thousands)
	Parent Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Assets
Current assets:
Cash and cash equivalents	$	20,437	$	27,507	$	58,716	$	—		$	106,660
Restricted cash and marketable securities	—		—		13,506		—			13,506
Accounts receivable, net	—		223,434		113,896		—			337,330
Supplies inventory	—		—		21,406		—			21,406
Prepaid and other current assets	28,739		39,046		16,062		(8,076		)	75,771
Total current assets	49,176		289,987		223,586		(8,076		)	554,673
Property and equipment, net	12,515		14,601		162,052		—			189,168
Investments in and receivables from unconsolidated affiliates	4,901,026		1,775,272		—		(6,507,128		)	169,170
Goodwill	—		1,956,741		—		2,013,469			3,970,210
Intangible assets, net	12,780		1,579,537		2,320		—			1,594,637
Other assets	4,653		1,717		17,078		(1,998		)	21,450
Total assets	$	4,980,150	$	5,617,855	$	405,036	$	(4,503,733	)	$	6,499,308
Liabilities and Equity
Current liabilities:
Current portion of long-term debt	$	8,700	$	—	$	11,677	$	—		$	20,377
Accounts payable	2,816		3,760		29,837		(3,852		)	32,561
Accrued salaries and benefits	31,510		158,705		12,322		—			202,537
Accrued interest	30,463		—		17		—			30,480
Other accrued liabilities	13,962		76,590		32,909		(4,224		)	119,237
Total current liabilities	87,451		239,055		86,762		(8,076		)	405,192
Long-term debt	2,326,103		—		55,249		(23,396		)	2,357,956
Deferred income taxes	268,573		432,923		—		(1,998		)	699,498
Other long-term liabilities	4,560		71,509		20,114		—			96,183
Intercompany payable	—		1,228,157		—		(1,228,157		)	—
Noncontrolling interests – redeemable	—		—		63,060		112,672			175,732
Equity:
Total AmSurg Corp. equity	2,293,463		3,646,211		132,267		(3,778,478		)	2,293,463
Noncontrolling interests – non-redeemable	—		—		47,584		423,700			471,284
Total equity	2,293,463		3,646,211		179,851		(3,354,778		)	2,764,747
Total liabilities and equity	$	4,980,150	$	5,617,855	$	405,036	$	(4,503,733	)	$	6,499,308

Condensed Consolidating Statement of Operations



Condensed Consolidating Statement of Operations - For the Three Months Ended June 30, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Net revenue	$	7,700		$	437,042		$	324,047		$	(10,290	)	$	758,499
Operating expenses:
Salaries and benefits	22,246			305,173			76,727			(135		)	404,011
Supply cost	—			1,145			48,578			(20		)	49,703
Other operating expenses	6,034			44,213			71,033			(10,135		)	111,145
Transaction costs	2,099			3,036			—			—			5,135
Depreciation and amortization	1,103			21,192			7,759			—			30,054
Total operating expenses	31,482			374,759			204,097			(10,290		)	600,048
Net gain (loss) on disposals and deconsolidations	—			2,857			(262		)	—			2,595
Equity in earnings of unconsolidated affiliates	87,700			68,939			—			(149,288		)	7,351
Operating income	63,918			134,079			119,688			(149,288		)	168,397
Interest expense (income), net	(4,215		)	35,528			600			—			31,913
Earnings before income taxes	68,133			98,551			119,088			(149,288		)	136,484
Income tax expense	22,064			10,858			443			—			33,365
Net earnings	46,069			87,693			118,645			(149,288		)	103,119
Less net earnings (loss) attributable to noncontrolling interests	—			(7		)	57,057			—			57,050
Net earnings attributable to AmSurg Corp. shareholders	46,069			87,700			61,588			(149,288		)	46,069
Preferred stock dividends	(2,264		)	—			—			—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	43,805		$	87,700		$	61,588		$	(149,288	)	$	43,805



Condensed Consolidating Statement of Operations - For the Six Months Ended June 30, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Net revenue	$	16,244		$	852,872		$	634,659		$	(20,598	)	$	1,483,177
Operating expenses:
Salaries and benefits	46,341			614,753			153,024			(268		)	813,850
Supply cost	—			2,152			94,547			(33		)	96,666
Other operating expenses	13,652			87,552			137,920			(20,297		)	218,827
Transaction costs	2,276			4,249			—			—			6,525
Depreciation and amortization	2,175			41,528			15,423			—			59,126
Total operating expenses	64,444			750,234			400,914			(20,598		)	1,194,994
Net gain (loss) on disposals and deconsolidations	—			2,857			(262		)	—			2,595
Equity in earnings of unconsolidated affiliates	156,742			134,375			—			(277,187		)	13,930
Operating income	108,542			239,870			233,483			(277,187		)	304,708
Interest expense (income), net	(7,034		)	68,504			1,253			—			62,723
Earnings before income taxes	115,576			171,366			232,230			(277,187		)	241,985
Income tax expense	38,644			14,632			886			—			54,162
Net earnings	76,932			156,734			231,344			(277,187		)	187,823
Less net earnings (loss) attributable to noncontrolling interests	—			(7		)	110,898			—			110,891
Net earnings attributable to AmSurg Corp. shareholders	76,932			156,741			120,446			(277,187		)	76,932
Preferred stock dividends	(4,528		)	—			—			—			(4,528		)
Net earnings attributable to AmSurg Corp. common shareholders	$	72,404		$	156,741		$	120,446		$	(277,187	)	$	72,404



Condensed Consolidating Statement of Operations - For the Three Months Ended June 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries		Consolidating Adjustments			Total Consolidated
Net revenue	$	7,079		$	329,579		$	314,780	$	(9,488	)	$	641,950
Operating expenses:
Salaries and benefits	15,511			228,618			76,391		(124		)	320,396
Supply cost	—			489			45,335		(34		)	45,790
Other operating expenses	5,783			42,099			66,450		(9,330		)	105,002
Transaction costs	324			1,658			—		—			1,982
Depreciation and amortization	1,056			14,617			7,939		—			23,612
Total operating expenses	22,674			287,481			196,115		(9,488		)	496,782
Net gain (loss) on disposals and deconsolidations	—			(3,035		)	—		—			(3,035		)
Equity in earnings of unconsolidated affiliates	76,931			64,513			—		(137,455		)	3,989
Operating income	61,336			103,576			118,665		(137,455		)	146,122
Interest expense, net	11,978			17,624			580		—			30,182
Earnings before income taxes	49,358			85,952			118,085		(137,455		)	115,940
Income tax expense	15,683			9,021			489		—			25,193
Net earnings	33,675			76,931			117,596		(137,455		)	90,747
Less net earnings attributable to noncontrolling interests	—			—			57,072		—			57,072
Net earnings attributable to AmSurg Corp. shareholders	33,675			76,931			60,524		(137,455		)	33,675
Preferred stock dividends	(2,264		)	—			—		—			(2,264		)
Net earnings attributable to AmSurg Corp. common shareholders	$	31,411		$	76,931		$	60,524	$	(137,455	)	$	31,411



Condensed Consolidating Statement of Operations - For the Six Months Ended June 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Net revenue	$	14,170		$	615,158		$	601,409		$	(18,342	)	$	1,212,395
Operating expenses:
Salaries and benefits	33,154			440,219			149,454			(252		)	622,575
Supply cost	—			885			87,523			(34		)	88,374
Other operating expenses	12,417			71,710			129,501			(18,056		)	195,572
Transaction costs	592			2,861			—			—			3,453
Depreciation and amortization	1,890			28,924			15,616			—			46,430
Total operating expenses	48,053			544,599			382,094			(18,342		)	956,404
Net gain (loss) on disposals and deconsolidations	(188		)	(3,223		)	(35		)	188			(3,258		)
Equity in earnings of unconsolidated affiliates	137,318			119,096			—			(249,774		)	6,640
Operating income	103,247			186,432			219,280			(249,586		)	259,373
Interest expense, net	23,864			35,378			1,187			—			60,429
Earnings before income taxes	79,383			151,054			218,093			(249,586		)	198,944
Income tax expense	24,670			13,924			848			—			39,442
Net earnings	54,713			137,130			217,245			(249,586		)	159,502
Less net earnings attributable to noncontrolling interests	—			—			104,789			—			104,789
Net earnings attributable to AmSurg Corp. shareholders	54,713			137,130			112,456			(249,586		)	54,713
Preferred stock dividends	(4,528		)	—			—			—			(4,528		)
Net earnings attributable to AmSurg Corp. common shareholders	$	50,185		$	137,130		$	112,456		$	(249,586	)	$	50,185

Condensed Consolidating Statement of Cash Flows



Condensed Consolidating Statement of Cash Flows - For the Six Months Ended June 30, 2016 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by operating activities	$	39,294		$	131,227		$	255,297		$	(230,713	)	$	195,105
Cash flows from investing activities:
Acquisitions and related expenses	(265,258		)	(284,010		)	—			268,155			(281,113		)
Acquisition of property and equipment	(1,676		)	(19,916		)	(16,026		)	—			(37,618		)
Proceeds from sale of interests in surgery centers	—			25			—			—			25
Purchases of marketable securities	—			—			(498		)	—			(498		)
Maturities of marketable securities	—			—			2,738			—			2,738
Other	—			(4,057		)	(4,692		)	—			(8,749		)
Net cash flows used in investing activities	(266,934		)	(307,958		)	(18,478		)	268,155			(325,215		)
Cash flows from financing activities:
Proceeds from long-term borrowings	313,000			—			4,151			—			317,151
Repayment on long-term borrowings	(92,350		)	(9		)	(6,404		)	—			(98,763		)
Distributions to owners, including noncontrolling interests	—			(102,330		)	(243,972		)	230,713			(115,589		)
Capital contributions	—			265,258			—			(265,258		)	—
Changes in intercompany balances with affiliates, net	(2,657		)	—			2,657			—			—
Other, net	(6,199		)	2,520			1,332			(2,897		)	(5,244		)
Net cash flows provided by (used in) financing activities	211,794			165,439			(242,236		)	(37,442		)	97,555
Net decrease in cash and cash equivalents	(15,846		)	(11,292		)	(5,417		)	—			(32,555		)
Cash and cash equivalents, beginning of period	20,437			27,507			58,716			—			106,660
Cash and cash equivalents, end of period	$	4,591		$	16,215		$	53,299		$	—		$	74,105



Condensed Consolidating Statement of Cash Flows - For the Six Months Ended June 30, 2015 (In thousands)
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating Adjustments			Total Consolidated
Cash flows from operating activities:
Net cash flows provided by (used in) operating activities	$	(27,553	)	$	172,907		$	232,423		$	(126,382	)	$	251,395
Cash flows from investing activities:
Acquisitions and related expenses	(51,852		)	(197,718		)	—			53,538			(196,032		)
Acquisition of property and equipment	(4,490		)	(9,424		)	(18,751		)	—			(32,665		)
Purchases of marketable securities	—			—			(1,245		)	—			(1,245		)
Maturities of marketable securities	—			—			2,988			—			2,988
Other	—			(1,441		)	(546		)	—			(1,987		)
Net cash flows used in investing activities	(56,342		)	(208,583		)	(17,554		)	53,538			(228,941		)
Cash flows from financing activities:
Proceeds from long-term borrowings	—			—			7,795			—			7,795
Repayment on long-term borrowings	(4,350		)	—			(5,938		)	—			(10,288		)
Distributions to owners, including noncontrolling interests	—			(15,108		)	(212,307		)	126,382			(101,033		)
Capital contributions	—			51,852			—			(51,852		)	—
Changes in intercompany balances with affiliates, net	444			—			(444		)	—			—
Other financing activities, net	(2,892		)	2,573			1,287			(1,686		)	(718		)
Net cash flows provided by (used in) financing activities	(6,798		)	39,317			(209,607		)	72,844			(104,244		)
Net increase (decrease) in cash and cash equivalents	(90,693		)	3,641			5,262			—			(81,790		)
Cash and cash equivalents, beginning of period	134,351			23,471			50,257			—			208,079
Cash and cash equivalents, end of period	$	43,658		$	27,112		$	55,519		$	—		$	126,289